CME Group Inc.
CME Group to Sell Osttra for $3.1 Billion to KKR
Summary
CME Group Inc. announced on April 14, 2025, the sale of Osttra Group Ltd., its joint venture with S&P Global Inc., to investment funds managed by KKR for $3.1 billion. Osttra, established in 2021, is a leading provider of post-trade solutions for the global OTC market. The transaction, expected to close in the second half of 2025, is subject to regulatory approvals and customary closing conditions. CME Group and S&P Global will each receive $1.55 billion from the sale.
Profitelligence Alerts
Get alerts for CME
Be first to know when CME Group Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About CME Group Inc.
CME Group Inc. is a leading global marketplace for derivatives and futures trading. It provides a diverse range of products, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. CME Group's primary function is to facilitate risk management and price discovery, offering a centralized marketplace where traders can hedge against fluctuations in these various markets. Notable features include its electronic trading platform, CME Globex, enabling seamless access to its services worldwide, and its clearing services, ensuring the integrity and stability of the financial system. CME Group is crucial for market participants who require precise risk management tools, boasting significant influence in sectors like agriculture, energy, and global finance. As one of the largest futures and options exchanges, CME Group plays a pivotal role in the financial market by providing liquidity, transparency, and efficiency in trading activities.
Official SEC Documents
Advertisement